Search results for: 'PFAS testing in soil'

18 Aug 2020  |  Global  |  Frost Radar

Frost Radar™: Global Testing, Inspection, and Certification Market, 2020

A Benchmarking System to Spark Companies to Action—Innovation that Fuels New Deal Flow and Growth Pipelines

Infographics

×

The global testing, inspection, and certification market is fragmented and intensely competitive. New entrants in home markets and lost opportunities from government institution and in-house testing have been compounding incumbents challenges. Market participants have been embracing digital transformation with solutions that can provide real-time...

The non-destructive testing (NDT) inspection services market rebounded in 2017 after two years of negative growth. It is expected to transform over the next five years with the advent of new technologies, changing customer requirements regarding connectivity and analytics features, and novel business models. The market was worth $8.79 billion in 20...

23 Dec 2020  |  Global  |  Market Research

Digital Transformation Powers the Global Testing, Inspection, and Certification Market

Service Innovations and Adjacent Market Penetration Opportunities Enabled by 5G, IoT, AI/ML, and Environmental Sustainability Drive Transformational Growth

Infographics

×

Key Issues Addressed

In the global testing, inspection, and certification (TIC) market independent conformity assessments are carried out by regulatory bodies, accredited and certified third-party companies, and organizations. The TIC market represents conformity assessments of products, goods, operations, systems, and management, but not financial auditing. This stud...

26 Jun 2020  |  Global  |  Market Research

Global Noise, Vibration and Harshness (NVH) Testing Market, Forecast to 2024

More Simulation-based Solutions Should Drive Market Revenues in the Coming Years

Infographics

×

This Frost & Sullivan research service analyzes the global noise, vibration and harshness (NVH) testing market in detail for the period covering 2018 to 2024, with 2019 as the base year. The study covers both the hardware and software segments. Hardware includes sensors, analyzers, sound level meters, microphones, data acquisition systems, signal c...

In 2003, the first human genome sequence was produced, with a production cost between $500 million and $1 billion. However, since 2008, when next-generation sequencing (NGS) approaches entered the research setting, there has been a significant decline in sequencing costs. These approaches allow either the whole genome (via whole-genome sequencing [...

The objective of this growth insight is to identify the key growth opportunities for NDT service providers and NDT equipment suppliers in China, South Korea, and Japan. To achieve this objective, the growth insight starts with discussing the key Mega Trends that are affecting end-user industries as well as the key market trends and technology trend...

Accelerated reforms due to COVID-19 and technologically advanced sample-in-answer-out portable, web-connected, encrypted devices that provide results in a few minutes changed the diagnostic healthcare industry. Decentralized testing empowers clinicians to make lifesaving decisions for the patient. It shortens supply chain lag time, saves costs of i...

Cardiac troponin (cTn) biomarkers are the gold standard in myocardial infarction (MI) diagnosis, leading healthcare professionals to use cTn diagnostics. In addition, a rising number of patients visit emergency departments (EDs) with cardiac complaints, increasing ED demand for kits that can rapidly rule MI in or out. Both factors serve as signif...

14 Mar 2022  |  North America  |  Market Outlook

Next-generation Diagnostics Outlook, 2022

Recovery in Routine Testing and Focus on Personalized Diagnostics to Propel Growth

Infographics

×

In vitro diagnostics introduces new technologies, sequencing methods, novel software algorithms, and multi-omics approaches to realise the goal of personalized medicine. Next-generation diagnostics has been the backbone of COVID-19-related emergency diagnosis, with an estimated 25% to 30% of revenue during 2020 and early 2021 related to this testin...